Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Radiotherapy

Preoperative chemoradiotherapy for rectal cancer

Chemoradiotherapy and surgical resection are important elements of multimodality treatment for patients with locally advanced rectal cancer. The optimum sequence of these modalities has been addressed in several randomized trials and preoperative chemoradiotherapy has been shown to be superior to postoperative treatment for a variety of end points.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med. 312, 465–472 (1985).

  2. Krook, J. E. et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med. 324, 709–715 (1991).

    Article  CAS  Google Scholar 

  3. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264, 1444–1450 (1990).

  4. Roh, M. S. et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J. Clin. Oncol. 27, 5124–5130 (2009).

    Article  Google Scholar 

  5. Sauer, R. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351, 1731–1740 (2004).

    Article  CAS  Google Scholar 

  6. Frykholm, G. J., Glimelius, B. & Påhlman, L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis. Colon Rectum 36, 564–572 (1993).

    Article  CAS  Google Scholar 

  7. Glimelius, B., Gronberg, H., Jarhult, J., Wallgren, A. & Cavallin-Ståhl, E. A. systematic overview of radiation therapy effects in rectal cancer. Acta. Oncol. 42, 476–492 (2003).

    Article  Google Scholar 

  8. Sebag-Montefiore, D. et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373, 811–820 (2009).

    Article  Google Scholar 

  9. Rodel, C. & Sauer, R. Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther. Onkol. 183, 227–235 (2007).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author is on the Speakers bureau of Merck, Roche and Sanofi-Aventis and receives grant/research support from Merck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rödel, C. Preoperative chemoradiotherapy for rectal cancer. Nat Rev Clin Oncol 7, 129–130 (2010). https://doi.org/10.1038/nrclinonc.2010.10

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2010.10

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer